EN
HI
Sandu Pharmaceuticals share price chart
Sandu Pharmaceuticals Share Key Metrics
Volume
1191.00
Market Cap
39.19 CR
LTQ@LTP
100@41.00
ATP
40.98
Var Margin
25 %
Circuit Range
32.8-49.2
Delivery %
81.87 %
Value
48807.18
ASM/GSM
No
Market Lot
1
Summary
SANDUPHQ stock price is ₹41 as of 12 Jul, 2026. The stock intraday movement has stayed between ₹40.67 and ₹41.47, while Sandu Pharmaceuticals share price 52 week high low is ₹30.00 & ₹58.28.
In terms of trading activity, SANDUPHQ share price has recorded a volume of 1,191 shares. The Sandu Pharmaceuticals has a market cap of ₹9660990. The stock’s Average Traded Price (ATP) stands at ₹40.98, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 100 @ ₹41.00.
The Sandu Pharmaceuticals upper circuit limit is ₹49.20 & The Sandu Pharmaceuticals lower circuit limit is ₹32.80, with a Value of ₹48807.18. The Delivery Percentage for the day is 81.87%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Sandu Pharmaceuticals Fundamentals
P/E Ratio
25.52
P/B Ratio
1.18
Div. Yield
2.44
Sector P/E
61.72
Sector P/B
3.24
Sec. Div. Yield
0.53
Sandu Pharmaceuticals Resistance and Support
Pivot 40.86
Resistance
First Resistance
41.22
Second Resistance
41.86
Third Resistance
42.22
Support
First Support
40.22
Second Support
39.86
Third Support
39.22
Sandu Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-11 | Others |
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-10-14 | Others |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
Sandu Pharmaceuticals News
Sandu Pharmaceuticals Ltd - 524703 - Announcement Under Regulation 30-Reconstitution Of Committees Of Board-Audit/Nomination/Stakeholders
Sandu Pharmaceuticals has redesignated Balram Viswanathan as Chairman and Managing Director for a 3-year term, effective July 11, 2026. This leadership change follows the recent demise of the former MD, Umesh B. Sandu, ensuring management continuity.
Jul 11 2026 17:36:40
Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Change in Directorate
Sandu Pharmaceuticals informed about the demise of its Managing Director, Shri Umesh B. Sandu, on June 19, 2026. Subsequently, Shri Balram Viswanathan was redesignated as Chairman and Managing Director, effective July 11, 2026.
Jul 11 2026 17:32:53
Read More
Sandu Pharmaceuticals Management
| Name | Position |
|---|---|
| Balram Viswanathan | Non Executive Independent Director |
| Ajit R Kantak | Non Executive Independent Director |
Sandu Pharmaceuticals Similar Stocks
Sandu Pharmaceuticals FAQs
The Buying Price of Sandu Pharmaceuticals share is 41 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Sandu Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sandu Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Sandu Pharmaceuticals shares is 25.52. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Sandu Pharmaceuticals shares is 1.18. Useful to assess the stock's value relative to its book value.
To assess Sandu Pharmaceuticals’s valuation compare Sector P/E, P/B which are 61.72 & 3.24 with sector averages, along with growth rates and financial metrics.
The Market Cap of Sandu Pharmaceuticals is 39.19 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Sandu Pharmaceuticals share price is 58.28 & 30.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Sandu Pharmaceuticals belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
